| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.0096 | 0.8 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.0098 | 0.8 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | -0.0082 | 0.8 |
| mRNA | JQ-1:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0081 | 0.8 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.0088 | 0.8 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | 0.0093 | 0.8 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | -0.0084 | 0.8 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.0093 | 0.8 |